MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2020

    Performance at the Category-Exemplars language test (CATEX) in Parkinson’s disease and Huntington’s disease Italian population

    R. Biundo, T. Gandolfi, M. Garon, E. Fiorenzato, G. Arcara, C. Jaquemont, P. Bisiacchi, C. Semenza, A. Antonini (Venice-Lido, Italy)

    Objective: This study aims to explore CATEX sensitivity to detect early cognitive deficits in Huntington’s disease (HD) and Parkinson’s disease (PD) Italian population. Background: PD…
  • MDS Virtual Congress 2020

    Differential impact of Lewy body disease and Alzheimer’s disease neuropathology on cognition

    S. Ryman, M. Yutsis, L. Tian, V. Henderson, T. Montine, D. Salmon, D. Galasko, K. Poston (Stanford, CA, USA)

    Objective: To examine the impact of Lewy body disease neuropathology (LBD) on domain-specific cognitive impairment in isolation and in combination with Alzheimer’s disease neuropathologic change…
  • MDS Virtual Congress 2020

    Repetitive transcranial magnetic stimulation (rTMS) fails to improve cognition in patients with Parkinson’s disease: a meta-analysis of randomized controlled trials

    P. He, L. Wang, J. Chen, Y. Zhang, Y. Gao, Q. Xu, Y. Qiu, H. Cai, Y. Li, Z. Huang, S. Feng, J. Zhao, G. Ma, K. Nie, L. Wang (Guangzhou, China)

    Objective: This study aimed to evaluate the effects of rTMS for improving cognition of PD patients. Background: Up to 20%–50% of patients with Parkinson’s disease…
  • MDS Virtual Congress 2020

    Influence of emotion-affective apathy in theory of mind in Parkinson’s disease patients

    O. Lucas-Jiménez, N. Ojeda, J. Peña, I. Gabilondo, A. Murueta-Goyena, J.C Gómez-Esteban, R. del Pino, M. Acera, N. Ibarretxe-Bilbao (Bilbao, Spain)

    Objective: The study aimed to investigate apathy subdomains (reward deficiency syndrome, emotional distress, executive function, auto-activation deficit) and cognitive executive functions differences between PD patients…
  • MDS Virtual Congress 2020

    Gender differenes in cognitive functioning in de novo Parkinson’s disease patients

    A. Slomp, S. vd Zee, J. Boertien, J. Spikman, T. van Laar (Groningen, Netherlands)

    Objective: To clarify the differences in cognitive functioning across different cognitive domains, between male and female de novo PD patients. Background: Parkinson’s disease (PD) is…
  • MDS Virtual Congress 2020

    Genome-wide association studies of progression in Parkinson’s disease

    M. Tan, M. Shoai, M. Lawton, S. Kanavou, N. Wood, J. Hardy, Y. Ben-Shlomo, N. Williams, M. Hu, D. Grosset, H. Morris (London, United Kingdom)

    Objective: To identify genetic variants associated with composite (cross-domain), motor, and cognitive progression in Parkinson’s disease (PD). Background: Case-control genome-wide association studies (GWASs) in PD…
  • MDS Virtual Congress 2020

    Diffusion Magnetic Resonance Imaging with Neurite Orientation and Dispersion Imaging (NODDI) Detects Early Localized Cortex Disruption in Parkinson’s Disease

    W. Sweidan, N. Seraji-Bozorgzad, J. Stanley, E. George (Detroit, MI, USA)

    Objective: To use diffusion kurtosis MRI with NODDI to assess brain cortex microstructure in Parkinson’s patients and localize disease related changes. Background: Cortical atrophy has…
  • MDS Virtual Congress 2020

    The Cognitive Training In Parkinson Study (COGTIPS), a randomized controlled trial

    T. van Balkom, H. Berendse, Y. v.d. Werf, J. Twisk, R. Hagen, T. Berk, O. v.d. Heuvel, C. Vriend (Amsterdam, Netherlands)

    Objective: In this randomized controlled trial [1], our objective was to assess the effect of online home-based cognitive training on objective cognitive functioning and subjective…
  • MDS Virtual Congress 2020

    Association between the number of CAG repetitions and cognitive performance in Huntington’s disease in patients of the National Institute of Neurology and Neurosurgery “MVS”

    D. Gasca-Saldaña, A. Vega-Rosas, G. Palma-Cordero, O. Castellanos-Maya (CDMX, Mexico)

    Objective: To establish the relationship between the number of CAG repetitions and the total Montreal Cognitive Assessment (MoCA) scores in patients with Huntington disease (HD).…
  • MDS Virtual Congress 2020

    Exploring cognitive aspect of linguistic prosody in Parkinson’s disease

    A. Basirat, S. Pinto, K. Dujardin, L. Defebvre, D. Devos, C. Moreau (Lille, France)

    Objective: To explore the correlation between linguistic prosody and cognition in Parkinson's disease Background: Around 90% of patients with Parkinson’s disease (PD) report speech deficit.…
  • « Previous Page
  • 1
  • …
  • 65
  • 66
  • 67
  • 68
  • 69
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley